VAM plans for San Diego shape up: ‘The June gloom will be history’

Registration for the live, in-person 2021 Vascular Annual Meeting (VAM) has begun—and organizers promise you won’t want to miss the meeting. VAM will be Aug. 18 to 21 in beautiful San Diego, California. Educational programming will be presented across all…
Pearls of wisdom for interns

It’s June and, in less than a month, a swarm of new faces, and freshly minted MDs and DOs will descend upon most academic teaching hospitals. Many will just be getting used to being called “Dr.” They may look around…
DEI: One speciality, many voices, diverse perspectives

Over the course of the last year, the Society for Vascular Surgery (SVS) has been on a journey toward fostering greater diversity, equity and inclusion (DEI). From the nadir of #Medbikini almost a year ago, the SVS Executive Board has…
Overcoming prejudice and uniting vascular surgery

The United States has been living through some charged times recently. Our profession is not immune to these conflagrations. In recent times, minority members of the diverse specialty of vascular surgery have seen people who look like them come under…
Being queer without proximal or distal control

“What do you mean your partner? Does that mean a man?” These were among the questions one of my mentors asked me when we were discussing my list of pros and cons regarding the vascular surgery residency training programs to…
Patient: ‘Whole body wellness includes the mind and body’

Kathryn Bowser, MD, a member of the Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee, talks to Justin Michel, 29, who identifies as a non-binary trans masculine person, about the patient experience navigating medical care as an…
Does this loofah make me look gay?

I doubt many people remember a specific time they watched C-SPAN, let alone the exact date. But on Dec. 18, 2010, there I was, in my Durham, North Carolina, apartment, watching the U.S. Senate vote on the Don’t Ask, Don’t Tell…
Philips announces positive two-year data from TOBA II BTK clinical trial

Royal Philips recently announced positive two-year results from the TOBA (Tack optimized balloon angioplasty) II below-the-knee (BTK) clinical trial. The data show the Philips Tack endovascular system (4F), a first-of-its kind dissection repair device, provides a sustained treatment effect and positive…
Stenting found to be superior to atherectomy, balloon angioplasty in reducing PAD mortality risk

Stenting reduced mortality risk in patients undergoing interventions for peripheral arterial disease (PAD) by more than 30% when compared to plain balloon angioplasty, and 40% contrasted with atherectomy, a recent propensity-matched analysis found. The Vascular Quality Initiative (VQI)-derived data drew…
SVS: Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When COVID hit, it intensified our focus on what was truly…

